Miranda Luís, Negreiro Filipa, Queiroz M J, Silva C
Instituto Português de Reumatologia, Lisboa.
Acta Reumatol Port. 2008 Apr-Jun;33(2):189-97.
Evaluate the relationship between activity functional and quality of life (QoL) measures with the costs supported by the Portuguese patients with ankylosing spondylitis (AS) in Portugal.
Observational and cross-sectional study performed in patients with AS diagnosis independent from the stage of the disease. Sociodemographics data use of health resources activity functional and QoL scales were collected Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Bath Ankylosing Spondylitis Functional Index (BASFI) Health Assessment Questionnaire (HAQ) and EQ-5D including Visual Analogue Scale (VAS).
127 patients were included of whom 67.7% were male with an average age of 48.7 years (range 22-75 years). Among employed patients 20.6% needed to modify their professional activity due to AS. The mean duration of the disease was 14.4 years. It was observed in the last year that 85.0% of the patients performed on average 7 visits to the physician due to AS 89.0% and 67.7% performed laboratory analysis and other exams respectively 67.5% performed physiotherapy treatments 3.1% were hospitalized and 85.8 were taking medication for AS. The median total cost supported by an AS patient was 525 Euro. It was observed the following average scores 5 in BASDAI 4.9 in BASFI 1.1 in HAQ and 58.7 in VAS. It was observed a statistically significant correlation between the total cost with the disease supported by the patient and BASDAI (r=0.257; p=0.004) and HAQ (r=0.299; p=0.010) scales.
The results indicate that a worst state of health turn into a higher cost for the patients.
评估葡萄牙强直性脊柱炎(AS)患者的活动功能和生活质量(QoL)指标与所承担费用之间的关系。
对诊断为AS的患者进行观察性横断面研究,不考虑疾病阶段。收集社会人口统计学数据、卫生资源使用情况、活动功能和QoL量表,包括巴斯强直性脊柱炎疾病活动指数(BASDAI)、巴斯强直性脊柱炎功能指数(BASFI)、健康评估问卷(HAQ)和EQ-5D,包括视觉模拟量表(VAS)。
纳入127例患者,其中67.7%为男性,平均年龄48.7岁(范围22 - 75岁)。在就业患者中,20.6%因AS需要调整职业活动。疾病平均病程为14.4年。去年观察到,85.0%的患者因AS平均就诊7次,89.0%和67.7%的患者分别进行了实验室分析和其他检查,67.5%的患者接受了物理治疗,3.1%的患者住院,85.8%的患者正在服用AS药物。AS患者承担的总费用中位数为525欧元。观察到以下平均得分:BASDAI为5分,BASFI为4.9分,HAQ为1.1分,VAS为58.7分。观察到患者承担的疾病总费用与BASDAI量表(r = 0.257;p = 0.004)和HAQ量表(r = 0.299;p = 0.010)之间存在统计学显著相关性。
结果表明,患者健康状况越差,费用越高。